bc500016k_si_001.pdf (2.78 MB)
Investigating Hapten Clustering as a Strategy to Enhance Vaccines against Drugs of Abuse
journal contribution
posted on 2015-12-17, 01:05 authored by Karen
C. Collins, Kim D. JandaVaccines for drugs of abuse have
yet to achieve full clinical relevance,
largely due to poor/inconsistent immune responses in patients. The
use of multivalent scaffolding as a means to tailor drug–hapten
density and clustering was examined in the context of drug-immune
response modulation. A modular trivalent hapten containing a diglycine
spacer, triAM1(Gly)2, was synthesized and shown to elicit
anti-nicotine antibodies at equivalent affinity and concentration
to the monovalent AM1 analog, despite in this instance having a lower
effective hapten density. Augmenting this data, the corresponding
monovalent hapten AM1(Gly)2 resulted in enhanced antibody
affinity and concentration. Drug-hapten clustering represents a new
vaccine paradigm, and, while examined only in the context of nicotine,
it should be readily translatable to other drugs of abuse.